Kvantify Qrunch Launches, Revolutionizing Quantum Computing for Chemistry

Kvantify Qrunch: Transforming Quantum Computing for Chemistry and Biology

On November 19, 2025, Kvantify, a Danish software company specializing in quantum computing, announced the launch of its flagship product, Qrunch, during the SC25 conference in St. Louis. This innovative platform aims to enhance efficiency and accelerate advancements in the fields of chemical and biological engineering.

Bridging the Gap in Quantum Computing

Simulations are a cornerstone of drug discovery and biotechnology. Quantum computing stands out as a promising avenue to expedite these simulations, yet its adoption has been hampered by several key barriers: limited accessibility for non-experts, insufficient scalability for real-world problems, and prohibitive cost-effectiveness. Qrunch addresses these issues head-on, offering a user-friendly interface that abstracts complex quantum operations, allowing domain scientists to develop and implement quantum algorithms without needing deep quantum knowledge. This ultimately reduces workflow development time significantly in comparison to direct programming on quantum hardware.

Nikolaj Zinner, the Chief Scientist at Kvantify, elaborated on this unique advantage of Qrunch: "Our focus on quantum computing tailored to chemistry allows full utilization of quantum hardware on-chip. Traditional quantum software tends to access only 10-30% of available qubits, whereas Qrunch leverages chemistry-specific strategies to enable efficient execution across complete processor architectures. This has been validated through molecular simulations employing up to 80 qubits in current quantum processors, showcasing a 3 to 4-fold improvement in problem-solving capacity compared to conventional methods."

The Impact on Pharmaceuticals and Material Science

For the pharmaceutical industry and materials science, such advancements translate into reduced project timelines, broader capabilities to manage molecular systems, and the possibility of modeling larger, commercially relevant molecules. Lars Olsen, a Senior Department Director at Novonesis, noted, "With this level of computation and subsequent analysis of enzyme behavior during catalysis, we gain deeper insights into fundamental biological processes, which can enhance the efficiency of our current enzymatic products."

Qrunch positions quantum computing as a transformative technology that broadens the scope of problems solvable in computational chemistry. Its compatibility with a wide spectrum of current gate-based quantum computers, including those accessible via Amazon Braket, the quantum computing service of Amazon Web Services (AWS), enhances its appeal and usability.

Partnered with IQM Quantum Computers, a leader in superconducting quantum computing rooted in Europe, Kvantify solidifies its stance in the European quantum ecosystem. "High-performance quantum software is essential for commercializing quantum computing, and Kvantify Qrunch provides just that. We are excited to collaborate with Kvantify to fortify the European quantum ecosystem and harness synergies between hardware and software," said Jan Goetz, Co-CEO and Co-founder of IQM Quantum Computers.

Availability and Future Prospects

Qrunch is now available for use, poised to make a significant impact on how industries approach chemical and biological innovation. More information about the product can be found on Kvantify's official website.

As Kvantify continues its mission to revolutionize molecular discovery by merging classical and quantum computing methodologies, Qrunch stands as a testament to the possibilities that arise when cutting-edge technology meets real-world challenges. This launch marks a pivotal advancement in the journey toward harnessing quantum computing in critical sectors, potentially reshaping pharmaceutical research and development as we know it.

For more detailed inquiries about Qrunch, visit Kvantify.